BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:55:58 PM | Browse: 6 | Download: 22
 |
Received |
|
2025-05-09 10:32 |
|
Peer-Review Started |
|
2025-05-09 10:32 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-17 08:22 |
|
Revised |
|
2025-05-19 02:12 |
|
Second Decision |
|
2025-06-06 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-06-06 06:30 |
|
Articles in Press |
|
2025-06-06 06:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-01 00:18 |
|
Publish the Manuscript Online |
|
2025-07-14 12:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Yttrium-90 microsphere therapy for hepatocellular carcinoma: Clinical efficacy, mechanistic insights, and comparative therapeutic perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yu-Hang Zhu, Ming-Wei Wang, Yan Jiao, Ya-Hui Liu and Shan-Shan Dong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ya-Hui Liu, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Xinmin Street, Changchun 130021, Jilin Province, China. yahui@jlu.edu.cn |
| Key Words |
Hepatocellular carcinoma; Yttrium-90 microsphere therapy; Radioembolization; Dosimetry; Clinical outcomes; Comparative efficacy |
| Core Tip |
Yttrium-90 (Y-90) microsphere therapy effectively prolongs overall survival and progression-free survival in hepatocellular carcinoma patients, demonstrating excellent tumor response rates and minimal severe adverse events. Advanced dosimetry and integration with systemic therapies further enhance its efficacy. Compared to conventional treatments, Y-90 offers improved local tumor control and better safety, marking it a pivotal component in contemporary multimodal cancer management. |
| Publish Date |
2025-07-14 12:55 |
| Citation |
<p>Zhu YH, Wang MW, Jiao Y, Liu YH, Dong SS. Yttrium-90 microsphere therapy for hepatocellular carcinoma: Clinical efficacy, mechanistic insights, and comparative therapeutic perspectives. <i>World J Gastrointest Oncol</i> 2025; 17(7): 109379</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/109379.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.109379 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
